🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Anavex Life Sciences Corp.

AVXL Healthcare
$2.5 +$0.1 (4.17%)
Market Cap: $231.68 M
Gurus Holding
3
Popularity Rank
#2753
% of Shares Held
1.16%
Net Activity (Q1 2026)
+$1.78 M

Guru Ownership Trend

Guru Analysis for Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Corp. (AVXL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.69 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $1.78 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 988.8%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$2.77 M
Total Buy Value
New Buys 1
Additions 2
-$989,744
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
3

FAQs for Anavex Life Sciences Corp. (AVXL)

Major holders include Cliff Asness ($2.32 M), Renaissance Technologies (RenTech) ($849,776), Paul Tudor Jones ($131,114). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.08 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.78 M, with 3 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited AVXL. The total reported sell value was $989,744.

Yes, 1 managers opened new positions in AVXL, and 2 increased their existing holdings. The total reported buy value was $2.77 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 405.2% 756,792 $2.32 M Q1 2026
0.00% Add 988.8% 276,800 $849,776 Q1 2026
0.00% New Buy 42,708 $131,114 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form